BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 37202515)

  • 1. Towards a future where Alzheimer's disease pathology is stopped before the onset of dementia.
    van der Flier WM; de Vugt ME; Smets EMA; Blom M; Teunissen CE
    Nat Aging; 2023 May; 3(5):494-505. PubMed ID: 37202515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional interventions for Alzheimer's prevention: a clinical precision medicine approach.
    Schelke MW; Hackett K; Chen JL; Shih C; Shum J; Montgomery ME; Chiang GC; Berkowitz C; Seifan A; Krikorian R; Isaacson RS
    Ann N Y Acad Sci; 2016 Mar; 1367(1):50-6. PubMed ID: 27116241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Alzheimer's Disease: Lessons Learned and Applied.
    Galvin JE
    J Am Geriatr Soc; 2017 Oct; 65(10):2128-2133. PubMed ID: 28766695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of the ABOARD project (A Personalized Medicine Approach for Alzheimer's Disease).
    Dreves MAE; van Harten AC; Visser LNC; Rhodius-Meester H; Köhler S; Kooistra M; Papma JM; Honey MIJ; Blom MM; Smets EMA; de Vugt ME; Teunissen CE; van der Flier WM;
    Alzheimers Dement (N Y); 2023; 9(2):e12401. PubMed ID: 37287472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection and personalized medicine: Future strategies against Alzheimer's disease.
    Di Meco A; Vassar R
    Prog Mol Biol Transl Sci; 2021; 177():157-173. PubMed ID: 33453940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The road to precision medicine: Eliminating the "One Size Fits All" approach in Alzheimer's disease.
    Behl T; Kaur I; Sehgal A; Singh S; Albarrati A; Albratty M; Najmi A; Meraya AM; Bungau S
    Biomed Pharmacother; 2022 Sep; 153():113337. PubMed ID: 35780617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer's Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project.
    Malzbender K; Barbarino P; Barkman Ferrell P; Bradshaw A; Brookes AJ; Díaz C; van der Flier WM; Georges J; Hansson O; Hartmanis M; Jönsson L; Krishnan R; MacLeod T; Mangialasche F; Mecocci P; Minguillon C; Middleton L; Pla S; Sardi SP; Schöll M; Suárez-Calvet M; Weidner W; Visser PJ; Zetterberg H; Bose N; Solomon A; Kivipelto M
    J Prev Alzheimers Dis; 2024; 11(2):329-338. PubMed ID: 38374739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach.
    Isaacson RS; Ganzer CA; Hristov H; Hackett K; Caesar E; Cohen R; Kachko R; Meléndez-Cabrero J; Rahman A; Scheyer O; Hwang MJ; Berkowitz C; Hendrix S; Mureb M; Schelke MW; Mosconi L; Seifan A; Krikorian R
    Alzheimers Dement; 2018 Dec; 14(12):1663-1673. PubMed ID: 30446421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives of patients, care partners, and primary care physicians on management of mild cognitive impairment and mild Alzheimer's disease dementia.
    Brunton S; Pruzin JJ; Alford S; Hamersky C; Sabharwal A; Gopalakrishna G
    Postgrad Med; 2023 Jun; 135(5):530-538. PubMed ID: 37219410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized, Precision Medicine to Cure Alzheimer's Dementia: Approach #1.
    Fessel J
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
    Castrillo JI; Lista S; Hampel H; Ritchie CW
    Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the prevention of Alzheimer's Disease.
    Sindi S; Mangialasche F; Kivipelto M
    F1000Prime Rep; 2015; 7():50. PubMed ID: 26097723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early detection of Alzheimer's disease and approaches for prevention].
    Jessen F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Mar; 62(3):255-260. PubMed ID: 30680409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered Approach.
    Morató X; Pytel V; Jofresa S; Ruiz A; Boada M
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers and Precision Medicine in Alzheimer's Disease.
    Sagar R; Pathak P; Pandur B; Kim SJ; Li J; Mahairaki V
    Adv Exp Med Biol; 2021; 1339():403-408. PubMed ID: 35023132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer's disease.
    Sagud M; Tudor L; Pivac N
    Expert Rev Neurother; 2021 May; 21(5):571-589. PubMed ID: 33749488
    [No Abstract]   [Full Text] [Related]  

  • 18. The future of Alzheimer's disease: the next 10 years.
    Hampel H; Prvulovic D; Teipel S; Jessen F; Luckhaus C; Frölich L; Riepe MW; Dodel R; Leyhe T; Bertram L; Hoffmann W; Faltraco F;
    Prog Neurobiol; 2011 Dec; 95(4):718-28. PubMed ID: 22137045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical issues in Alzheimer's disease: an overview.
    Leuzy A; Gauthier S
    Expert Rev Neurother; 2012 May; 12(5):557-67. PubMed ID: 22550984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?
    Messner DA; Rabins P; Downing AC; Irizarry M; Foster NL; Al Naber J; Dabbous O; Fillit H; Gabler S; Krakauer R; Lotz D; Payzant E; Schneider L; Tyrone J; Van Amerongen D; Wuest D
    J Prev Alzheimers Dis; 2019; 6(1):20-26. PubMed ID: 30569082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.